Bibliome.ai browser hg19
Search
About
Stats
FAQ
TET2 c.3865T>A ;(p.C1289S)
Variant ID: 4-106180837-T-A
NM_001127208.2(
TET2
):c.3865T>A;(p.C1289S)
This variant was identified in 5 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
Genome Medicine
Cai, Ming-Ci MC; Cheng, Shu S; Wang, Xin X; Hu, Jian-Da JD; Song, Yong-Ping YP; Huang, Yao-Hui YH; Yan, Zi-Xun ZX; Jiang, Yu-Jie YJ; Fang, Xiao-Sheng XS; Zheng, Xiao-Yun XY; Dong, Li-Hua LH; Ji, Meng-Meng MM; Wang, Li L; Xu, Peng-Peng PP; Zhao, Wei-Li WL
Publication Date: 2020-04-30
Variant appearance in text: TET2: C1289S
PubMed Link:
32349779
Variant Present in the following documents:
13073_2020_739_MOESM1_ESM.pdf
View BVdb publication page
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.
Nature Communications
Nagata, Yasunobu Y; Makishima, Hideki H; Kerr, Cassandra M CM; Przychodzen, Bartlomiej P BP; Aly, Mai M; Goyal, Abhinav A; Awada, Hassan H; Asad, Mohammad Fahad MF; Kuzmanovic, Teodora T; Suzuki, Hiromichi H; Yoshizato, Tetsuichi T; Yoshida, Kenichi K; Chiba, Kenichi K; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Miyano, Satoru S; Mukherjee, Sudipto S; LaFramboise, Thomas T; Nazha, Aziz A; Sekeres, Mikkael A MA; Radivoyevitch, Tomas T; Haferlach, Torsten T; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP
Publication Date: 2019-11-26
Variant appearance in text: TET2: C1289S
PubMed Link:
31772163
Variant Present in the following documents:
41467_2019_13001_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page
TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Molecular Genetics & Genomic Medicine
Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P
Publication Date: 2019-07
Variant appearance in text: TET2: Cys1289Ser
PubMed Link:
31187595
Variant Present in the following documents:
Main text
View BVdb publication page
The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Bmc Cancer
Wang, Ruiqi R; Gao, Xiaoning X; Yu, Li L
Publication Date: 2019-04-25
Variant appearance in text: TET2: C1289S
PubMed Link:
31023266
Variant Present in the following documents:
12885_2019_5602_MOESM2_ESM.xls, sheet 1
View BVdb publication page
A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.
Blood Cancer Journal
Baccelli, I I; Krosl, J J; Boucher, G G; Boivin, I I; Lavallée, V-P VP; Hébert, J J; Lemieux, S S; Marinier, A A; Sauvageau, G G
Publication Date: 2017-02-17
Variant appearance in text: TET2: C1289S
PubMed Link:
28211886
Variant Present in the following documents:
bcj201710x1.pdf
View BVdb publication page